News

Filter

Current filters:

LegalNovo Nordisk

1 to 9 of 11 results

Novo Nordisk accused of delaying information release under Danish STC rules

Novo Nordisk accused of delaying information release under Danish STC rules

10-12-2013

Danish insulin giant Novo Nordisk revealed this morning that the Danish Financial Supervisory Authority…

DenmarkDiabetesEuropeFinancialLegalNovo NordiskPharmaceuticalRyzodegTresiba

Sanofi latest to be implicated Chinese bribery allegations

09-08-2013

In the wake of allegations that several multinational pharma companies have engaged in unlawful marketing…

Asia-PacificLegalLundbeckMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Negative US patent ruling for Novo Nordisk on Prandin

19-06-2013

Denmark-based insulin giant Novo Nordisk (NOV: N) says that the US Court of Appeals for the Federal Circuit…

DiabetesGenericsLegalNovo NordiskPatentsPharmaceuticalPrandin

News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus

20-12-2012

Two US subsidiaries of French drug major Sanofi (Euronext: SAN) have agreed to pay $109 million to resolve…

Amicus TherapeuticsAmigalDiabetesFIAspFinancialGlaxoSmithKlineHyalganIDegLiraLegalNorth AmericaNovo NordiskPharmaceuticalRare diseasesResearchSanofi

UCB agrees $34.4 million settlement for off-label promotion of Keppra in USA; Novo to pay $25 million over NovoSeven

13-06-2011

The US subsidiary of Belgian pharmaceutical manufacturer UCB SA (Euronext Brussels: UCB) last week pleaded…

DiabetesKeppraLegalMarkets & MarketingNeurologicalNorth AmericaNovo NordiskNovoSevenPharmaceuticalUCB

Novo Nordisk subpoenaed in the USA over marketing

16-02-2011

Danish insulin giant Novo Nordisk says it has received a subpoena from the office of the US Attorney…

DiabetesLegalNorth AmericaNovo NordiskPharmaceuticalRegulationVictoza

1 to 9 of 11 results

COMPANY SPOTLIGHT

Menarini

Back to top